openPR Logo

Press Releases from DelveInsight Business Research LLP (4751 total)

Autosomal Dominant Optic Atrophy Market to Witness Growth by 2032 | PYC Therapeu …

DelveInsight's "Autosomal Dominant Optic Atrophy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Autosomal Dominant Optic Atrophy, historical and forecasted epidemiology

Autoimmune Pulmonary Alveolar Proteinosis Market | Savara Pharmaceuticals, Bridg …

DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology

Autoimmune Hepatitis Market to Witness Growth | Novartis, TaiwanJ Pharmaceutical …

DelveInsight's "Autoimmune Hepatitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Autoimmune Hepatitis, historical and forecasted epidemiology as well as the

Complicated Urinary Tract Infections (UTI) Pipeline Analysis (2023) Covering Cli …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 12+ key pharma and biotech companies are working on 12+ pipeline drugs in

Progressive Supranuclear Palsy Pipeline Analysis (2023) Covering Clinical Trials …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 15+ pipeline drugs in

Myotonic Dystrophy Pipeline Analysis (2023) Covering Clinical Trials, Emerging T …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 22+ pipeline drugs in

Gonorrhea Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 12+ key pharma and biotech companies are working on 12+ pipeline drugs in

Carcinoid Syndrome Pipeline Analysis (2023) Covering Clinical Trials, Emerging T …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on various pipeline therapies in the

Open-Angle Glaucoma Pipeline Analysis (2023) Covering Clinical Trials, Emerging …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in

Schistosomiasis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Ther …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on developing various pipeline therapies in

Pancreatic Ductal Adenocarcinoma (PDAC) Pipeline Analysis (2023) Covering Clinic …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 80+ key pharma and biotech companies are working on 80+ pipeline drugs in

Pancreatic Ductal Adenocarcinoma (PDAC) Pipeline Analysis (2023) Covering Clinic …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 80+ key pharma and biotech companies are working on 80+ pipeline drugs in

Pancreatic Cancer Pipeline Analysis (2023) Covering Clinical Trials, Emerging Th …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 290+ key pharma and biotech companies are working on 300+ pipeline drugs in

Myasthenia Gravis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Th …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the

Gallbladder Cancer Market to Witness Growth by 2032 | Celgene, MedImmune, Ohara …

DelveInsight's "Gallbladder Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Gallbladder Cancer, historical and forecasted epidemiology as well as the

ESR1-Mutated Metastatic Breast Cancer Market to Witness Growth by 2032 | Arvinas …

DelveInsight's "ESR1-Mutated Metastatic Breast Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of ESR1-Mutated Metastatic Breast Cancer, historical and forecasted epidemiology

Ependymoma Market to Witness Growth by 2032, asserts DelveInsight | Fera Pharmac …

DelveInsight's "Ependymoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Ependymoma, historical and forecasted epidemiology as well as the Ependymoma market

Common Warts Market to Witness Growth by 2032 | Nielsen BioSciences, Veloce BioP …

DelveInsight's "Common Warts Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Common Warts, historical and forecasted epidemiology as well as the

Chronic Liver Disease Market to Witness Growth by 2032 | Astellas Pharma, Bristo …

DelveInsight's "Chronic Liver Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Liver Disease, historical and forecasted epidemiology as well

Methicillin Resistant Staphylococcus Aureus Pipeline, Clinical Trials Studies, E …

DelveInsight's, "Methicillin-Resistant Staphylococcus Aureus Infections Pipeline Insight 2023" report provides comprehensive insights about 25+ companies and 27+ pipeline drugs in Methicillin-Resistant Staphylococcus Aureus Infections pipeline

Nosocomial Pneumonia Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers …

DelveInsight's, "Nosocomial Pneumonia Pipeline Insight, 2023," report provides comprehensive insights about 13+ companies and 13+ pipeline drugs in the Nosocomial Pneumonia pipeline landscape. It covers

Eosinophilic Esophagitis Pipeline, FDA Approvals, Clinical Trials Studies, and L …

DelveInsight's, "Eosinophilic Esophagitis Pipeline Insight 2023" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Eosinophilic Esophagitis pipeline landscape. It covers

Oral Mucositis Pipeline, FDA Approvals, Clinical Trials Developments and Compani …

(Albany, United States) As per DelveInsight's assessment, globally, the Oral Mucositis Pipeline constitutes 10+ Oral Mucositis companies continuously working towards developing 10+ Oral Mucositis Pipeline

Follicular Lymphoma Pipeline, FDA Approvals, Clinical Trials Developments and Co …

DelveInsight's, "Follicular Lymphoma Pipeline Insight 2023" report provides comprehensive insights about 50+ Follicular Lymphoma companies and 50+ pipeline drugs in the Follicular Lymphoma pipeline landscape.

Moderate to Severe Inflammatory Acne Vulgaris Pipeline, FDA Approvals, Clinical …

DelveInsight's, "Moderate to Severe Inflammatory Acne Vulgaris Pipeline Insight 2023" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Moderate to

C-MET Non-Small Cell Lung Cancer Pipeline, FDA Approvals, Clinical Trials Develo …

DelveInsight's, "C-MET Non-Small Cell Lung Cancer (C-MET+ NSCLC) - Pipeline Insight, 2023," report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the

Adrenoleukodystrophy Pipeline, FDA Approvals, Clinical Trials Developments and C …

DelveInsight's, "Adrenoleukodystrophy Pipeline Insight, 2023," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Adrenoleukodystrophy pipeline landscape. It covers the Adrenoleukodystrophy

NK Cell Therapy Pipeline, FDA Approvals, Clinical Trials Developments and Compan …

DelveInsight's, "NK Cell Therapy Pipeline Insight 2023" report provides comprehensive insights about 100+ companies and 185+ pipeline drugs in the NK Cell Therapy pipeline landscape.

Behçet's Disease Pipeline, FDA Approvals, Clinical Trials Developments and Comp …

DelveInsight's, "Behçet's Disease Pipeline Insight 2023" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Behçet's Disease pipeline landscape. It covers Behçet's

Hypoglycemia Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapi …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in

Postoperative Pain Pipeline Analysis (2023) Covering Clinical Trials, Emerging T …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 45+ key pharma and biotech companies are working on 50+ pipeline drugs in

Influenza Virus B Infections Pipeline Analysis (2023) Covering Clinical Trials, …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in

Renal Anemia Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapi …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in

Non-Alcoholic Fatty Liver Disease (NAFLD) Pipeline Analysis (2023) Covering Clin …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 110+ key pharma and biotech companies are working on 160+ pipeline drugs in

Lung Adenocarcinoma Pipeline Analysis (2023) Covering Clinical Trials, Emerging …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in

Glomerulonephritis Pipeline Analysis (2023) Covering Clinical Trials, Emerging T …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on various pipeline therapies in the

HER2 Negative Metastatic Breast Cancer Pipeline Analysis (2023) Covering Clinica …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in

Non-Small Cell Lung Cancer (NSCLC) Pipeline Analysis (2023) Covering Clinical Tr …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 135+ key pharma and biotech companies are working on 150+ pipeline drugs in

Hypertension Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapi …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 100+ key pharma and biotech companies are working on 100+ pipeline drugs in

Myositis Pipeline, FDA Approvals, Clinical Trials Developments and Companies 202 …

DelveInsight's, "Myositis Pipeline Insight 2023," report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Myositis pipeline landscape. It covers the Myositis

Constipation Pipeline, FDA Approvals, Clinical Trials Developments and Companies …

DelveInsight's, "Constipation Pipeline Insight 2023" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Constipation pipeline landscape. It covers the Constipation

Alpha-1 Antitrypsin Deficiency Pipeline, FDA Approvals, Clinical Trials Developm …

DelveInsight's, "Alpha1-Antitrypsin Deficiency Pipeline Insight 2023" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Alpha1-Antitrypsin Deficiency pipeline landscape. It covers

Cirrhosis Pipeline, FDA Approvals, Clinical Trials Developments and Companies 20 …

DelveInsight's, "Cirrhosis Pipeline Insight, 2023," report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Cirrhosis pipeline landscape. It covers the Cirrhosis

Crohn's Disease Pipeline, FDA Approvals, Clinical Trials Developments and Compan …

DelveInsight's, "Crohn's Disease Pipeline Insight, 2023," report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn's Disease pipeline landscape. It covers the

Post-Polycythemia Vera Myelofibrosis Pipeline Analysis (2023) Covering Clinical …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 17+ key pharma and biotech companies are working on 17+ pipeline drugs in

Overactive Bladder Pipeline Analysis (2023) Covering Clinical Trials, Emerging T …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 15+ pipeline drugs in

Chemotherapy-Induced Peripheral Neuropathy (CIPN) Pipeline Analysis (2023) Cover …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 13+ key pharma and biotech companies are working on 13+ pipeline drugs in

Synovial Sarcoma Pipeline Analysis (2023) Covering Clinical Trials, Emerging The …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 14+ key pharma and biotech companies are working on 14+ pipeline drugs in

Chronic Hepatitis B Virus Pipeline Analysis (2023) Covering Clinical Trials, Eme …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in

Atopic Dermatitis Pipeline, FDA Approvals, Clinical Trials Developments and Comp …

DelveInsight's, "Atopic Dermatitis Pipeline Insight 2023" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers

Go To Page:    61 62 63 64 65 66 67 68 69 70